Logotipo do repositório
 

Publicação:
Evaluation of cytotoxicity and genotoxicity of a novel oxovanadium complex with orotate

dc.contributor.authorda Silva Gomes, Pietra Stefany
dc.contributor.authorda Silva, Washington Wilson
dc.contributor.authorde Cássia Gasparoti, Gabriela
dc.contributor.authorPayolla, Filipe Boccato
dc.contributor.authorde Oliveira, Jonata Augusto [UNESP]
dc.contributor.authorBarbugli, Paula Aboud [UNESP]
dc.contributor.authorMarin-Dett, Freddy Humberto [UNESP]
dc.contributor.authorCavicchioli, Maurício
dc.contributor.authorMassabni, Antonio Carlos
dc.contributor.authorResende, Flávia Aparecida
dc.contributor.institutionUNIARA – University of Araraquara
dc.contributor.institutionUniversidade Estadual Paulista (UNESP)
dc.date.accessioned2023-07-29T13:31:11Z
dc.date.available2023-07-29T13:31:11Z
dc.date.issued2022-11-01
dc.description.abstractThe development of new drugs based on metal complexes requires a detailed analysis of their biological endpoints. In this study, we report the genotoxic profile and influence on cell proliferation and death of the oxovanadium(IV) complex with orotic acid ([VO(C5H4N2O4)2], VO(oro)). Human hepatocellular carcinoma cells (HepG2) were the most sensitive tumor cells to VO(oro), which interfered with the integrity of cell membranes and proliferative capacity in a dose-dependent manner, inducing cell death by apoptosis. Regarding genotoxicity, VO(oro) did not induce considerable levels of DNA damage in HepG2 cells (comet test) and gene mutations (Ames test). However, it caused a statistically significant increase in the frequency of micronuclei at the highest concentration tested (12.5 µmol.L–1), indicating aneuploidy and clastogenicity. The data presented here provide information on various biological aspects of the VO(oro) complex, which may allow the elucidation of its mechanism of action as a possible therapeutic agent.en
dc.description.affiliationUNIARA – University of Araraquara Department of Biological Sciences and Health, São Paulo
dc.description.affiliationUNESP – São Paulo State University Faculty of Pharmaceutical Sciences of Araraquara Department of Natural Active Principles and Toxicology, São Paulo
dc.description.affiliationUNESP – São Paulo State University School of Dentistry of Araraquara, São Paulo
dc.description.affiliationUnespUNESP – São Paulo State University Faculty of Pharmaceutical Sciences of Araraquara Department of Natural Active Principles and Toxicology, São Paulo
dc.description.affiliationUnespUNESP – São Paulo State University School of Dentistry of Araraquara, São Paulo
dc.description.sponsorshipFundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
dc.description.sponsorshipCoordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)
dc.description.sponsorshipIdFAPESP: 2013/09265-7
dc.description.sponsorshipIdFAPESP: 2017/16278-9
dc.description.sponsorshipIdCAPES: 88887.335189/2019-00
dc.identifierhttp://dx.doi.org/10.1016/j.mrgentox.2022.503558
dc.identifier.citationMutation Research - Genetic Toxicology and Environmental Mutagenesis, v. 883-884.
dc.identifier.doi10.1016/j.mrgentox.2022.503558
dc.identifier.issn1879-3592
dc.identifier.issn1383-5718
dc.identifier.scopus2-s2.0-85143331211
dc.identifier.urihttp://hdl.handle.net/11449/247983
dc.language.isoeng
dc.relation.ispartofMutation Research - Genetic Toxicology and Environmental Mutagenesis
dc.sourceScopus
dc.subjectCytotoxicity
dc.subjectGenomic instability
dc.subjectMutagenicity
dc.subjectOxovanadium complex
dc.subjectToxicogenetics
dc.titleEvaluation of cytotoxicity and genotoxicity of a novel oxovanadium complex with orotateen
dc.typeArtigo
dspace.entity.typePublication
unesp.departmentPrincípios Ativos Naturais e Toxicologia - FCFpt

Arquivos